ArticleBMJ open ophthalmology2025
Bowman's layer and corneal thickness in health and disease.
Article in BMJ open ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate central Bowman's layer thickness (BT) in relation to central corneal thickness (CCT) and curvature, and epithelial thickness in healthy and disease corneas.
methodsPatients with keratoconus (KC), corneal dystrophies (CD) and healthy controls (HC) were included. Linnik and Mirau versions of an ultra-high axial resolution line field spectral domain optical coherence tomography device were used to image the cornea, in addition to commercially available devices. A supervised automated segmentation process was used to extract the quasi-point thickness of Bowman's layer.
results62 participants: 24 with KC, 20 with CD and 18 HC were included. Mean central BT was 15.41 µm (SD 0.49; min-max: 12.28-19.54) in HC, 14.27 µm (SD:0.43; min-max: 11.22-18.25) in KC and 15.65 µm (SD 0.64; min-max: 12.42-20.06) in CD (mainly Fuchs CD). Patients with KC had thinner central BT than those with CD (p=0.03), but not compared with HC (p=0.13). Central BT was significantly associated with CCT (p<0.01), being on average 3% of CCT. The ratio of BT to CCT was independent of diagnosis (CD 0.028, HC 0.030, KC 0.028, p=0.88), age (p=0.23), sex (p=0.67), Kmax (p=0.77) or epithelial thickness (p=0.72).
conclusionsOver sample populations of healthy, keratoconic and dystrophic corneas, central BT was consistently associated with corneal thickness and was independent of age, sex, Kmax, and epithelial thickness. TRIAL REGISTRATION NUMBER: ISRCTN40558.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.